Now, a new vaccine designed to train the body’s immune system to attack this rogue protein is showing promise in early trials ...

Findings from a Phase I trial initiated by Dana-Farber Cancer Institute have showed NeoVaxMI's improved immune response in melanoma patients.

Stem cell tech simulates ALS, quantum tools decode quasicrystals, and cancer exploits a human mutation—three breakthroughs ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...